uniQure N.V. Ordinary Shares vs Valaris Limited Common Shares — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while Valaris Limited Common Shares trades at $84.73 (market cap $5.94B). The key difference: Valaris Limited Common Shares is far larger — about 4× uniQure N.V. Ordinary Shares's market cap, and Valaris Limited Common Shares is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Valaris Limited Common Shares for 0 Days on average.
| QURE | VAL | |
|---|---|---|
Market Cap | $1.48B | $5.94B |
Volume | 2,488,780 | 742,554 |
Sector | Health | Energy |
52-Week High | $70.59 | $113.42 |
52-Week Low | $9.03 | $48.15 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $728.62M | $6.56B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Valaris Limited provides offshore contract drilling services to the oil and gas industry, operating a fleet of drillships, semisubmersibles, and jackup rigs across multiple regions worldwide.
Read more on VAL →